Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-10-01 (TLI) Adjuvant Therapy in Stage III Melanoma
NCT00925314Phase 2Unknown
- Start
- Jun 2007
- Primary completion
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CB-10-01 in melanoma. Status: unknown.
02
Drugs
CB-10-01
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00925314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925314.